Clinical trial Recruiting at 6 sites Observational Ages 20 and up

Evaluating the effectiveness of drug-eluting balloons for coronary artery disease

Official title: Evaluation of Effectiveness and Safety of Drug-Eluting Balloon in Routine Clinical Practice; A Multicenter Prospective Observational Cohort Study

Run by Asan Medical Center · NCT02038660 · Data updated 2026-11-12

This study is testing how well drug-eluting balloons work for treating coronary artery disease in real-life settings and keeping patients safe after their balloon angioplasty.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages20 Years and up
SexAll
Enrollment1500 (estimated)
SponsorAsan Medical Center
Academic / other
Locations9 sites (Bucheon-si and 8 other locations)
StatusRecruiting
StartedJanuary 2014
Main results expectedDecember 31, 2026
Study endsJune 2027
Registry record updatedDecember 29, 2025
Trial IDNCT02038660 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 20 and older who have undergone balloon angioplasty for coronary artery disease.

Probably not a fit

Patients with allergies to paclitaxel or antiplatelet medications, or those with a history of bleeding disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the long-term effectiveness and safety of drug-eluting balloons used in balloon angioplasty for patients with coronary artery disease in real-world clinical settings. Participants will be monitored after receiving treatment to gather data on outcomes and any potential complications. The study includes patients aged 20 and older who have undergone balloon angioplasty and meet specific inclusion criteria, while those with certain allergies or bleeding disorders will be excluded.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term benefits and safety of drug-eluting balloons, potentially improving treatment strategies for coronary artery disease.

How similar studies have gone: Other studies have shown promising results with drug-eluting balloons in similar contexts, indicating a potential for success in this observational study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
* Age 20 and more
* Treated with Balloon angioplasty
* Signed informed consent and agreed to follow protocol

Exclusion Criteria:

* Allergy to paclitaxel, antiplatelet
* History of side effect to heparin, aspirin, thienopyridines
* History of bleeding tendency, coagulation disorder, blood transfusion reaction

Where it's running

  • Keimyung University Dongsan Medical Center
    Daegu, South Korea
    Recruiting
  • Chonnam National University Hospital
    Gwangju, South Korea
    Recruiting
  • Dong-A Medical Center
    Pusan, South Korea
    Recruiting
  • Asan Medical Center
    Seoul, South Korea
    Recruiting
  • Gangnam Severance Hospital
    Seoul, South Korea
    Recruiting
  • Ulsan University Hospital
    Ulsan, South Korea
    Recruiting
Show 3 more locations
  • Soon Chun Hyang University Hospital Bucheon
    Bucheon-si, South Korea
    Terminated
  • The Catholic University of Korea, Daejeon ST. Mary's Hospital
    Daejeon, South Korea
    Terminated
  • Korea University Guro Hospital
    Seoul, South Korea
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.